SCLN
Sciclone Pharmaceuticals Inc
SCLN
SCLN
Delisted
SCLN was delisted on the 13th of October, 2017.
133 hedge funds and large institutions have $341M invested in Sciclone Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 41 increasing their positions, 52 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less capital invested
Capital invested by funds: $860M → $341M (-$519M)
Holders
133
Holding in Top 10
1
Calls
$67K
Puts
$1K
Top Buyers
| 1 | +$3.7M | |
| 2 | +$3.67M | |
| 3 | +$3.48M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.21M |
| 5 |
Renaissance Technologies
New York
|
+$1.28M |
Top Sellers
| 1 | -$607M | |
| 2 | -$8.57M | |
| 3 | -$8.17M | |
| 4 |
PP
PDT Partners
New York
|
-$2.39M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$2.34M |